Literature DB >> 228946

Separation of human brain angiotensin-converting enzyme from enkephalin-degrading activity.

A Arregui, C M Lee, P C Emson, L L Iversen.   

Abstract

Angiotensin-converting enzyme and enkephalin-degrading enzyme activities were solubilized and purified from a particulate fraction of human diencephalon. Converting enzyme activity and enkephalin-degrading activity elute in different fractions following ion exchange chromatography on DEAE-cellulose, suggesting that they are different enzymes. Both enzymes were purified further by ion exchange chromatography on hydroxylapatite and by gel filtration on Sephadex G-200. The purified enzymes had markedly different sensitivities to known inhibitors of angiotensin-converting enzyme. The data do not support the hypothesis that angiotensin-converting enzyme and enkephalin degrading-enzyme are identical.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228946     DOI: 10.1016/0014-2999(79)90037-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases.

Authors:  H Schweisfurth; S Schiöberg-Schiegnitz; W Kuhn; B Parusel
Journal:  Klin Wochenschr       Date:  1987-10-15

2.  The influence of naloxone on the circulatory effects of captopril.

Authors:  P C Rubin; J A Millar; S Sturani; C Lawrie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 3.  Pituitary endopeptidases.

Authors:  M Orlowski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

4.  Nootropic effects of ACE inhibitors in mice.

Authors:  C Mondadori; P Etienne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Proteases of human brain.

Authors:  A Pope; R A Nixon
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

6.  Captopril and opiate antagonism in essential hypertension.

Authors:  A A Ajayi; P C Rubin; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

7.  [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].

Authors:  K O Stumpe
Journal:  Klin Wochenschr       Date:  1985-09-16

Review 8.  Degradation of enkephalins: the search for an enkephalinase.

Authors:  L B Hersh
Journal:  Mol Cell Biochem       Date:  1982-08-20       Impact factor: 3.396

9.  Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.

Authors:  G P Bernini; A R Lucarini; M S Vivaldi; C Del Corso; M Lenzi; A Salvetti
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.